May 1, 2015 -- (AuntMinnie.com) The worldwide nuclear medicine imaging market for PET and SPECT equipment is on track to produce $2.2 billion in revenues by 2020, according to a new report by RnR Market Research.
Two Asian giants will lead growth opportunities, with the Japanese market share set to increase by... Read More
THURSDAY, April 2, 2015 (HealthDay News) -- Despite medical advances, new research indicates that more people are dying of heart disease and stroke worldwide than did a quarter century ago because the global population is growing, and growing older. The study is published in the April 2 issue of the New England... Read More
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the... Read More
March 17, 2015 -- Researchers from Utah found that PET/CT is far superior to SPECT for diagnosing myocardial ischemia, with higher sensitivity at a lower radiation dose, according to a paper presented on Sunday at the American College of Cardiology (ACC) meeting in San Diego. PET/CT in particular far outstripped... Read More
The Wall Street Transcript releases an interview with Positron's President & Chairman, Joseph G. Oliverio.
TWST: Can you provide an overview of Positron and summarize its value proposition?
Mr. Oliverio: We are a nuclear medicine health care company that specializes in the businesses of positron emission... Read More